Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF670-ZNF695 readthrough (NMD candidate) is a **naturally occurring read-through transcript** between the adjacent zinc finger protein 670 (ZNF670) and zinc finger protein 695 (ZNF695) genes located on chromosome 1. This transcript straddles both genes due to transcription readthrough, but it **is a candidate for nonsense-mediated mRNA decay (NMD)**, which means it is highly unlikely to be translated into a functional protein product. There is **no evidence this locus encodes a functional protein**, and it is not currently associated with any therapeutic or biomarker utility[1][3][6]. **Explanation:** - The entity is not a conventional gene product or receptor, but rather a readthrough non-coding RNA, primarily of **genomic/transcriptional interest** rather than therapeutic significance[1][3][6]. - There is no evidence it produces a protein or has a direct role as a transcription factor, enzyme, receptor, or other therapeutic target.[1][3][6] - No drugs or known mechanisms of action are associated with this readthrough transcript. - Its primary annotation is as an **NMD candidate—and thus not translated**[1][3]. If you are seeking information about the protein-coding genes themselves (ZNF670 or ZNF695), those are **zinc finger transcription factors** potentially involved in the regulation of gene expression and may have biological relevance, but the ZNF670-ZNF695 readthrough transcript should not be considered a therapeutic target[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF670-ZNF695 readthrough (NMD candidate) (ZNF670-ZNF695).